Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Exchange Rate Effect (2020 - 2025)

Mirum Pharmaceuticals has reported Exchange Rate Effect over the past 6 years, most recently at -$408000.0 for Q4 2025.

  • Quarterly results put Exchange Rate Effect at -$408000.0 for Q4 2025, up 70.41% from a year ago — trailing twelve months through Dec 2025 was $3.2 million (up 348.42% YoY), and the annual figure for FY2025 was $3.2 million, up 348.42%.
  • Exchange Rate Effect for Q4 2025 was -$408000.0 at Mirum Pharmaceuticals, down from $349000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for MIRM hit a ceiling of $2.2 million in Q2 2025 and a floor of -$1.4 million in Q4 2024.
  • Median Exchange Rate Effect over the past 5 years was $3000.0 (2021), compared with a mean of $94894.7.
  • Biggest five-year swings in Exchange Rate Effect: tumbled 1733.33% in 2022 and later surged 6366.67% in 2023.
  • Mirum Pharmaceuticals' Exchange Rate Effect stood at $5000.0 in 2021, then soared by 1600.0% to $85000.0 in 2022, then increased by 27.06% to $108000.0 in 2023, then tumbled by 1376.85% to -$1.4 million in 2024, then soared by 70.41% to -$408000.0 in 2025.
  • The last three reported values for Exchange Rate Effect were -$408000.0 (Q4 2025), $349000.0 (Q3 2025), and $2.2 million (Q2 2025) per Business Quant data.